Role of endothelium-derived nitric oxide in the regulation of blood pressure

Proc Natl Acad Sci U S A. 1989 May;86(9):3375-8. doi: 10.1073/pnas.86.9.3375.

Abstract

The role of endothelium-derived nitric oxide in the regulation of blood pressure in the anesthetized rabbit was studied with N omega-monomethyl-L-arginine (L-NMMA), a specific inhibitor of its formation from L-arginine. L-NMMA (3-100 mg.kg-1), but not its D-enantiomer, induced a dose-dependent long-lasting (15-90 min) increase in mean systemic arterial blood pressure. L-NMMA (100 mg.kg-1) also inhibited significantly the hypotensive action of acetylcholine, without affecting that of glyceryl trinitrate. Both these actions of L-NMMA were reversed by L-arginine (300 mg.kg-1), but not by D-arginine (300 mg.kg-1), indomethacin (1 mg.kg-1), prazosin (0.3 mg.kg-1), or by vagotomy. The effects of L-NMMA in vivo were associated with a significant inhibition of the release of nitric oxide from perfused aortic segments ex vivo. This inhibition was reversed by infusing L-arginine through the aortic segments. These results indicate that nitric oxide formation from L-arginine by the vascular endothelium plays a role in the regulation of blood pressure and in the hypotensive actions of acetylcholine.

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Blood Pressure* / drug effects
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / physiology*
  • Indomethacin / pharmacology
  • Kinetics
  • Male
  • Nitric Oxide / metabolism*
  • Nitroglycerin / pharmacology
  • Phenylephrine / pharmacology
  • Prazosin / pharmacology
  • Rabbits
  • Stereoisomerism
  • Vagotomy
  • omega-N-Methylarginine

Substances

  • Phenylephrine
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Nitroglycerin
  • Acetylcholine
  • Prazosin
  • Indomethacin